Related Experiment Video
Updated: May 1, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Disclosure of HIV diagnosis to children: a poorly addressed issue in pediatric HIV care
Insights
Disclosure of human immunodeficiency virus (HIV) status in children is vital for their health but often overlooked in clinical practice. This review highlights the need for guidelines to support effective HIV disclosure for pediatric patients.
Area of Science:
- Pediatric infectious diseases
- Adolescent health
- Public health
Background:
- Increasing survival rates of children with HIV due to antiretroviral therapy.
- HIV status disclosure is a critical but under-addressed aspect of pediatric HIV care.
- Disclosure offers significant health benefits for children living with HIV/AIDS.
Purpose of the Study:
- To review existing research on the disclosure of pediatric HIV infection.
- To identify challenges and best practices in communicating HIV status to children.
- To emphasize the importance of disclosure in the continuum of pediatric HIV care.
Main Methods:
- Literature review of studies on HIV status disclosure in children.
- Analysis of research focusing on challenges faced by healthcare workers and caregivers.
- Synthesis of findings related to the impact of disclosure on pediatric health outcomes.
Main Results:
- Disclosure is crucial for pediatric HIV care but is poorly implemented in routine practice.
- Healthcare providers and caregivers face unique challenges in disclosing HIV status to children.
- Developmentally appropriate information is key for effective disclosure.
Conclusions:
- There is a significant need for practical interventions and guidelines to support pediatric HIV disclosure.
- Effective disclosure strategies are essential for improving health outcomes for children with HIV.
- Further research and development of supportive resources are recommended to address disclosure challenges.
Abstract:
As antiretroviral therapy becomes more widely available in developing countries, increasing numbers of HIV infected children are surviving into adolescence and beyond. As they grow older, human immunodeficiency virus (HIV) serostatus disclosure presents a unique challenge to health care workers and care givers of children with HIV/AIDS. Although disclosure is a crucial component of the continuum of pediatric HIV care with proven health benefits, it is poorly addressed in routine clinical practice. The purpose of this paper is to provide a review of researches on disclosure of pediatric HIV infection. The need for practical interventions including a guideline development to support pediatric HIV disclosure which provides children with developmentally appropriate information about the disease is suggested.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Sexually Transmitted Infections
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

